Corcept Therapeutics CORT
NASDAQ CORT
$115.16 +0.42 (+0.37%)
As of: Sep 30, 2026 · 10:25 AM EDT

Corcept Therapeutics (CORT) Operating Expenses (2010 - 2026)

Updated

Corcept Therapeutics' Operating Expenses was $214.85 million in Q2 2026, up 28.1% from $167.76 million a year earlier and up 0.2% from the prior quarter.

Analysis

Corcept Therapeutics (CORT) Operating Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Corcept Therapeutics' Operating Expenses was $824.41 million through Jun 30, 2026, up 34.2% year-over-year; for FY2025, it came in at $716.61 million, up 33.2% from FY2024.

  • Operating Expenses has now increased for ten consecutive years, with a five-year compound annual growth rate of 26.0% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $538.09 million in FY2024 (+43.5%), $375.09 million in FY2023 (+29.7%), $289.22 million in FY2022 (+19.8%) and $241.5 million in FY2021 (+7.0%).
  • The Q2 2026 figure marks the highest quarterly Operating Expenses in data going back to Q2 2010.
  • Compared with a year earlier, Operating Expenses has increased for 19 straight quarters, with growth averaging 37.4% over the last eight quarters.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2024 (growth of 51.0%); the worst was Q3 2021 (a decline of 2.8%).
  • Per Business Quant data, CORT's Operating Expenses in the three quarters before Q2 2026 was $214.5 million (Q1 2026), $197.64 million (Q4 2025) and $197.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Corcept Therapeutics 12.50 Bn 11.06 Bn 252.09 Mn 214.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 214.85 Mn
Mar 31, 2026 214.50 Mn
Dec 31, 2025 197.64 Mn
Sep 30, 2025 197.42 Mn
Jun 30, 2025 167.76 Mn
Mar 31, 2025 153.80 Mn
Dec 31, 2024 156.63 Mn
Sep 30, 2024 135.95 Mn
Jun 30, 2024 128.20 Mn
Mar 31, 2024 117.31 Mn
Dec 31, 2023 103.74 Mn
Sep 30, 2023 92.42 Mn
Jun 30, 2023 88.13 Mn
Mar 31, 2023 90.80 Mn
Dec 31, 2022 80.56 Mn
Sep 30, 2022 69.79 Mn
Jun 30, 2022 71.95 Mn
Mar 31, 2022 66.92 Mn
Dec 31, 2021 62.16 Mn
Sep 30, 2021 59.90 Mn
API Access

Corcept Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=CORT&period=max&api_key=YOUR_API_KEY